New-generation mutitargeted tyrosine kinase inhibitors in the treatment of radioactive iodine-refractory differentiated thyroid cancer

Background. Thyroid cancer (TC) is one of the common oncological disease of the head and neck. However, its treatment is sharply restricted in a locally advanced and metastatic cancer process. In the past decade, there have been fundamental changes in the understanding of the molecular bases of thyr...

Full description

Saved in:
Bibliographic Details
Main Author: A. M. Mudunov
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/156
Tags: Add Tag
No Tags, Be the first to tag this record!